The study aims to evaluate an investigational vaccine against diseases caused by the respiratory syncytial virus (RSV) when given at the same time as the approved annual influenza vaccine.
To find out if this trial is suitable for you please register below, or contact our Clinical Trials Team at email@example.com or phone 6151 0888.
Eligibility & Requirements
- Healthy adults aged 65 years or older
- Willing and able to follow a study treatment plan of scheduled study visits, lab tests and other study procedures for the duration of the study, approximately 2 months
- You will be required to attend 3 visits over a 2 month period to Institute for Respiratory Health at the QEII Medical Centre in Nedlands to receive the investigational vaccine or placebo and also the annual approved influenza vaccine.
Sign up today
Bayesian Evidence-Adaptive Treatment in Cystic Fibrosis (BEAT CF)